Nal Pharmaceuticals, Ltd.

Nal Pharmaceutical Group Limited

Neogenestar LLC

Degussa Gmbh

Zheng Wang

Chitoor S Subramaniam

Je Phil Ryoo

Chun Kwong Chu

Diana Shu-Lian Chow

Nancy Quan

Richard J Kucera

Thor W Nilsen

Roland A Ako

This disclosure describes a novel, ready-to-use protease composition in the form of a film or pouch composition. The protease composition can be used for stabilizing a biological sample containing a nucleic acid molecule for storage or transportation. It allows quick removal of protein contamination in the biological sample, thus facilitating sample preparation for nucleic acid detection or extraction.

Protease compositions and methods of use thereof

Oral dosage forms as a biodegradable, water soluble film for delivering pharmaceutically active agents, to patients through insertion into the mouth of patient and methods for administering pharmaceutically active agents to patients by insertion into the mouth to provide selective uptake of said agents through the mucosa and thus avoiding the gastrointestinal tract.

Dosage form for insertion into the mouth

Oral dosage forms as a biodegradable, water soluble film for delivering pharmaceutically active agents, particularly diethylstilbestrol and pharmaceutically acceptable salts thereof to patients through insertion into the mouth of patient and methods for administering pharmaceutically active agents to patients by insertion into the mouth to provide selective uptake of said agents through the mucosa and thus avoiding the gastrointestinal tract.

Diethylstilbestrol dosage form and methods of treatment using thereof

Oral dosage forms and methods for delivering effective amounts of erectile dysfunction medicaments to patients to provide rapid uptake of said agents through the mucosa of the oral cavity are disclosed.

Oral dosage forms as a biodegradable, water soluble film for delivering pharmaceutically active agents, particularly anti-migraine agents to patients through insertion into the mouth of patient and methods for administering pharmaceutically active agents to patients by insertion into the mouth to provide selective uptake of said agents through the mucosa and thus avoiding the gastrointestinal tract.

Growing community of inventors

Bridgewater, NJ, United States of America

Zheng Wang